I agree, maybe it is better to focus on the FDA tr
Post# of 148185
(Total Views: 435)
Posted On: 05/28/2020 12:19:41 PM
I agree, maybe it is better to focus on the FDA trial as designed and ignore the noise from everything else in other trials and other drugs. After all, we only need 25 more patients and that might be in screening right now.
The severe trial of 390 patients is a whole different situation. If it takes months to enroll fully before any readout, that will be a disaster. The interesting thing is that Leronlimab's huge advantage against Covid is with severe cases, where all other drugs fail. In the mild cases we could be looked at as just another drug that might help but the patients might have gotten better on their own. I am sure the actual data from the mild trial will show far more than this but the media headline is much bigger when people are taken off ventilators. I hate to look at this this way, let's hope we can just simply appreciate that Leronlimab is helping and it needs to get to doctors ASAP
The severe trial of 390 patients is a whole different situation. If it takes months to enroll fully before any readout, that will be a disaster. The interesting thing is that Leronlimab's huge advantage against Covid is with severe cases, where all other drugs fail. In the mild cases we could be looked at as just another drug that might help but the patients might have gotten better on their own. I am sure the actual data from the mild trial will show far more than this but the media headline is much bigger when people are taken off ventilators. I hate to look at this this way, let's hope we can just simply appreciate that Leronlimab is helping and it needs to get to doctors ASAP
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼